glp-1 receptor agonists for type 2 diabetes Agonists: A Game-Changer GLP-1-based therapies for type 2

[51] World Health Organization

Then, further screening process was applied, guided by inclusion criteria of all the clinical trials that were involved the use of GLP-1 as a primary intervention for GDM, where all other studies were excluded

Systemic exenatide treatment can reverse aging-associated transcriptomic changes in various brain cell types in mice, including glial and neurovascular cells

Weight Loss While weight loss is often a desired effect of GLP-1 drugs, it can sometimes be excessive or rapid, leading to: Nutritional deficiencies Gallstones Muscle loss Monitoring weight and nutritional intake is important to ensure that weight loss remains within healthy limits

Mounjaro There have also been reports of urinary tract infections, or UTIs, as a rare Ozempic side effect